“gene-therapy” Archives

in
Entry Author Date Location
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
UniQure’s Shares Rise on Early Gene Therapy Data For Hemophilia 01/07/16 National
Stewart Parker: Biotech Thoughts On Gene Therapy, GOP & Trout Streams 12/31/15 Seattle
Xconomy’s Top 10 Innovation Stories of 2015 12/31/15 National
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio 11/19/15 San Diego
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
New Bluebird Data Hint at Gene Therapy’s Limits For Some Patients 11/05/15 Boston
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue 09/14/15 Boston
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
West Coast Biotech Roundup: BioMarin, Tocagen, Medivation, Twelve 08/27/15 San Diego
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
100 Years But Only One Drug: Sickle Cell Patients Wait For Help 08/18/15 National
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
Page 3 of 8 « previous page · next page »